FindTrial
Sign In

Safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) for the prevention of vestibular migraine

Safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) for the prevention of vestibular migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052387
Enrollment
Unknown
Registered
2021-10-24
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vestibular migraine

Interventions

experience group:repetitive transcranial magnetic stimulation
control group:Sham stimulation

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18~65 years old; 2. Patients with a definite diagnosis of vestibular migraine or vertigo syndrome subjects with a history of migraine; 3. The number of occurrences per month is not less than 3 times; 4. The subjects or their legal representatives can understand the purpose of the research, show sufficient compliance with the research protocol, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who have serious local or systemic diseases, such as severe cervical spine disease, fractures and traumatic brain injury, are not allowed to exercise; 2. The investigators believe that they are not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
vertigo;headache;—

Secondary

MeasureTime frame
Days of medication in acute phase;VAS pain rating scale;Dizziness Disability Rating Inventory (DHI);—

Countries

China

Contacts

Public ContactYu Dongzhen

Shanghai Sixth People's Hospital

drdzyu@126.com+86 18930173980

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026